Skip to main content
padlock icon - secure page this page is secure

Cognition is a Necessary Factor for Controlling Drug Abuse

Buy Article:

$68.00 + tax (Refund Policy)

Background: Drug abuse is one of the major concerns of human societies. The relapse of abusing drugs is one of the main targets of addiction therapies. Studies in this regard have introduced four basic mechanisms: 1) drug-induced reinforcement 2) cue-induced reinforcement 3) stress-induced reinforcement and 4) negative reinforcement.

Objective: In recent studies, cognition has got great interest in addiction research. It has been proposed that prefrontal cortex can reduce the risk of relapse, by influencing cognition. In this review, we are going to discuss the benefit of better cognition in the context of the above four basic mechanisms, not specifically prefrontal cortex.

Method: A literature search was conducted in all major indexing databases including Pubmed, Embase and Google Scholar. The included articles were not limited to the time of publication and all relevant articles were used.

Results: Our findings suggest that cognition is necessary for controlling drug abuse. Also, it was found that cognition may control relapse to drug abuse by influencing the four basic mechanisms that are responsible for relapse to drugs.

Conclusion: Cognition is a necessary factor for controlling drug abuse. It suggested paying special attention to cognition before implementing a plan for treatment of relapse to drug abuse.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Addiction; abuse; cue; reinstatement; relapse; stress

Document Type: Review Article

Publication date: December 1, 2018

More about this publication?
  • Current Psychiatry Reviews publishes frontier reviews on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians, psychiatrists and researchers in psychiatry.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more